Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

 

 

 

  

A 770041

 

CAS 869748-10-7

C34H39N9O3  MW 621.73

Purity: 99%

Soluble in DMSO to 100 mM

Soluble in 1 eq aq HCl to 28mM

 

 

 

 

 

Ordering Information:

 

Cat. No. Axon 1698     Prime Source

 

Qty1: 5 mg (research sample) / €135  $176

Promotion: 2 x 5 mg @  €200   $260

Qty2: 25 mg (research smaple) / €505  $657

Promotion: 2 x 25 mg @  €760   $988

Qty3: on request

 

Send enquiry to: order@axonmedchem.com

or by fax to: +31-50-3600390.

 

Contact us for payment and tech support.

Biological Activity:

 

Selective and orally active Src-family Lck inhibitor; A-770041 is a 147 nM inhibitor of Lck (1 mM ATP) and is 300-fold selective against Fyn, the other Src family kinase involved in T-cell signaling.

 

References:

 

RF Stachlewitz et al. A-770041, a Novel and Selective Small-Molecule Inhibitor of Lck, Prevents Heart Allograft Rejection. J. Pharmacol. Exp. Ther. 2005, 315(1), 36-41. [online]

 

 

 

 

Chemical Name: N-(4-(1-((1r,4r)-4-(4-acetylpiperazin-1-yl)cyclohexyl)-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide

 

A 770041 | Lck inhibitor | Axon Medchem | Axon 1698 | A770041

axonmedchem.com © 2011

 

Axon Ligands In The Field:

 

A 770041 | Lck inhibitor

 

AZD 0530 | Src-Abl inhibitor

Dasatinib | Bcr-Abl/Src inhibitor

Nilotinib | BCR-ABL inhibitor

PD 180970 | BCR-ABL inhibitor

Bosutinib | ABL/Src inhibitor

SU 6656 | Src inhibitor

 

Click Here To See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection

 

 

About LcK

Lck, one of eight members of the Src family of tyrosine kinases, is activated after T cell stimulation and is required for T-cell proliferation and interleukin (IL)-2 production.